Deep Proteome Analysis of Cerebrospinal Fluid from Pediatric Patients with Central Nervous System Cancer

Christian Mirian1,2, Ole Østergaard2, Maria Thastrup1

  • 1Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark.

PubMed

Insights

Optimizing proteome analysis of pediatric cerebrospinal fluid (CSF) enables deeper biomarker discovery. This enhanced workflow maximizes protein identification from limited samples, aiding pediatric central nervous system malignancy research.

Area of Science:

  • Proteomics
  • Biomarker Discovery
  • Pediatric Oncology

Background:

  • Cerebrospinal fluid (CSF) is crucial for pediatric central nervous system malignancy biomarkers.
  • Challenges include wide protein concentration ranges, age-related differences, and limited sample volume.
  • Pediatric CSF samples are often scarce and prioritized for clinical use.

Purpose of the Study:

  • To optimize a proteome analysis workflow for pediatric CSF.
  • To maximize protein identification from limited CSF volumes for research.
  • To enhance biomarker discovery for pediatric central nervous system malignancies.

Main Methods:

  • Sequential ultracentrifugation to enrich extracellular vesicles (EVs).
  • Optimization of CSF input volume, digestion, gradient length, and data acquisition.
  • Application of protein aggregation capture (PAC) digestion and data-independent acquisition (DIA).

Main Results:

  • Quantification of 1351 proteins from 400 μL raw CSF with EV enrichment.
  • Increased protein identification to 2103 using a spectral library.
  • The optimized workflow identified 2989 unique proteins from 400 μL CSF, a 340% increase over raw CSF analysis.

Conclusions:

  • An optimized proteomic workflow significantly increases protein identification in pediatric CSF.
  • This method maximizes information from limited CSF samples, supporting biomarker discovery.
  • The enhanced workflow aids research into pediatric central nervous system malignancies.